BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17694945)

  • 1. Nine-year results following treatment of intrabony periodontal defects with an enamel matrix derivative: report of 26 cases.
    Sculean A; Schwarz F; Chiantella GC; Arweiler NB; Becker J
    Int J Periodontics Restorative Dent; 2007 Jun; 27(3):221-9. PubMed ID: 17694945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.
    Sculean A; Chiantella GC; Arweiler NB; Becker J; Schwarz F; Stavropoulos A
    Int J Periodontics Restorative Dent; 2008 Apr; 28(2):153-61. PubMed ID: 18546811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral.
    Döri F; Nikolidakis D; Húszár T; Arweiler NB; Gera I; Sculean A
    J Clin Periodontol; 2008 Jan; 35(1):44-50. PubMed ID: 18034853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intrabony defects with enamel matrix proteins or bioabsorbable membranes. A 4-year follow-up split-mouth study.
    Sculean A; Donos N; Miliauskaite A; Arweiler N; Brecx M
    J Periodontol; 2001 Dec; 72(12):1695-701. PubMed ID: 11811505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.
    Sculean A; Pietruska M; Arweiler NB; Auschill TM; Nemcovsky C
    J Clin Periodontol; 2007 Jun; 34(6):507-13. PubMed ID: 17451415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
    Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
    J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
    Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
    J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: an 8-year follow-up split-mouth study.
    Sculean A; Schwarz F; Miliauskaite A; Kiss A; Arweiler N; Becker J; Brecx M
    J Periodontol; 2006 Nov; 77(11):1879-86. PubMed ID: 17076614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enamel matrix derivative versus bioactive ceramic filler in the treatment of intrabony defects: 12-month results.
    Leknes KN; Andersen KM; Bøe OE; Skavland RJ; Albandar JM
    J Periodontol; 2009 Feb; 80(2):219-27. PubMed ID: 19186961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of EDTA root conditioning on the healing of intrabony defects treated with an enamel matrix protein derivative.
    Sculean A; Berakdar M; Willershausen B; Arweiler NB; Becker J; Schwarz F
    J Periodontol; 2006 Jul; 77(7):1167-72. PubMed ID: 16805678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of intrabony periodontal defects with an enamel matrix protein derivative (Emdogain): a report of 32 cases.
    Sculean A; Reich E; Chiantella GC; Brecx M
    Int J Periodontics Restorative Dent; 1999 Apr; 19(2):157-63. PubMed ID: 10635181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
    Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
    J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing of human intrabony defects following regenerative periodontal therapy with an enamel matrix protein derivative alone or combined with a bioactive glass. A controlled clinical study.
    Sculean A; Pietruska M; Schwarz F; Willershausen B; Arweiler NB; Auschill TM
    J Clin Periodontol; 2005 Jan; 32(1):111-7. PubMed ID: 15642068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study.
    Francetti L; Trombelli L; Lombardo G; Guida L; Cafiero C; Roccuzzo M; Carusi G; Del Fabbro M
    Int J Periodontics Restorative Dent; 2005 Oct; 25(5):461-73. PubMed ID: 16250568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects.
    Heden G; Wennström JL
    J Periodontol; 2006 Feb; 77(2):295-301. PubMed ID: 16460257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans.
    Sculean A; Barbé G; Chiantella GC; Arweiler NB; Berakdar M; Brecx M
    J Periodontol; 2002 Apr; 73(4):401-8. PubMed ID: 11990441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-year results following treatment of intrabony periodontal defects with an enamel matrix protein derivative: a report of 46 cases.
    Sculean A; Chiantella GC; Miliauskaite A; Brecx M; Arweiler NB
    Int J Periodontics Restorative Dent; 2003 Aug; 23(4):345-51. PubMed ID: 12956478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate.
    Döri F; Arweiler N; Gera I; Sculean A
    J Periodontol; 2005 Dec; 76(12):2236-43. PubMed ID: 16332235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year results following treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration.
    Sculean A; Donos N; Schwarz F; Becker J; Brecx M; Arweiler NB
    J Clin Periodontol; 2004 Jul; 31(7):545-9. PubMed ID: 15191590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.